Evidence map›Paper›PMID 25033019›Full record

ArticleCurrent opinion in microbiology2014

High-throughput sequencing for the study of bacterial pathogen biology.

Paul R McAdam, Emily J Richardson, J Ross Fitzgerald

Abstract read
In one paragraph

Article in Current opinion in microbiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Coexistence ofEnvironmental science & technology · 2023
    Article
  5. Article
  6. Characterization ofFrontiers in microbiology · 2023
    Article
  7. Review
  8. Article
  9. Editorial: Genome-Wide Analyses ofFrontiers in plant science · 2022
    Article
  10. Detecting Genetic Variation of ColonizingFrontiers in bioinformatics · 2022
    Article
  11. Article
  12. Article
  13. Genome-wide identification ofProceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  14. Article
  15. Standardization ofJournal of fungi (Basel, Switzerland) · 2018
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Paul R McAdamThe Roslin Institute and Edinburgh Infectious Diseases, University of Edinburgh, Easter Bush Campus, Edinburgh EH25 9RG, United Kingdom.
Emily J RichardsonThe Roslin Institute and Edinburgh Infectious Diseases, University of Edinburgh, Easter Bush Campus, Edinburgh EH25 9RG, United Kingdom.
J Ross FitzgeraldThe Roslin Institute and Edinburgh Infectious Diseases, University of Edinburgh, Easter Bush Campus, Edinburgh EH25 9RG, United Kingdom. Electronic address: Ross.Fitzgerald@ed.ac.uk.

Funding

Biotechnology and Biological Sciences Research Council BB/I013873/1
6 · The paper itself

Abstract

A revolution in sequencing technologies in recent years has led to dramatically increased throughput and reduced cost of bacterial genome sequencing. An increasing number of applications of the new technologies are providing broad insights into bacterial evolution, epidemiology, and pathogenesis. For example, the capacity to sequence large numbers of bacterial isolates is enabling high resolution phylogenetic analyses of bacterial populations leading to greatly enhanced understanding of the emergence, adaptation, and transmission of pathogenic clones. In addition, RNA-seq offers improved quantification and resolution for transcriptomic analysis, and the combination of high-throughput sequencing with transposon mutagenesis is a powerful approach for the identification of bacterial determinants required for survival in vivo. In this concise review we provide selected examples of how high throughput sequencing is being applied to understand the biology of bacterial pathogens, and discuss future technological advances likely to have a profound impact on the field.

Indexed as

BacteriaHigh-Throughput Nucleotide SequencingSequence Analysis, DNA

Identifiers

PMID25033019
PMCPMC4150483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.